Form D Explorer
Solstice Oncology, Inc. · CIK 2116600

Report a data issueCitable research briefCompare issuerPrivate research collection

Solstice Oncology, Inc.

CIK 2116600 · Corporation · Inc. DELAWARE · BOSTON, Massachusetts · Biotechnology
Filings
1
Original notices
1
Amendments
0
Activity
Mar 9, 2026
through Mar 9, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Mar 9, 2026

Reported offering amount
$298,400,851
Reported exemptions
Rule 506(b)
Reported amount sold
$121,260,306

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Related person name and locality match

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (1)